Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING FACIAL NERVE MICRO-ENTRAPMENT SYNDROME AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2024/051847
Kind Code:
A1
Abstract:
The present invention relates to a pharmaceutical composition for preventing and treating facial nerve micro-entrapment syndrome and a use thereof in the treatment of facial nerve micro-entrapment syndrome. The use comprises joint utilization of acupotomy, a radio frequency operation, acupoint injection of the pharmaceutical composition, and rehabilitative training.

Inventors:
CHEN LIN (CN)
WANG YU (CN)
GAO WENYONG (CN)
LI JIANJUN (CN)
Application Number:
PCT/CN2023/117899
Publication Date:
March 14, 2024
Filing Date:
September 09, 2023
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
BEIJING DARWIN BIOTECH CO LTD (CN)
International Classes:
A61K31/714; A61K9/08; A61K31/365; A61K31/573; A61K31/7032; A61K38/18; A61P21/00; A61P25/02
Foreign References:
US20150209390A12015-07-30
CN102988403A2013-03-27
CN111419866A2020-07-17
Other References:
李延龙等 (LI, YANLONG ET AL.): "注射用鼠神经生长因子联合腺苷钴胺在面神经炎治疗中的临床观察 (Non-official translation: Clinical Observation of Murine Nerve Growth Factor Combined with Adenosylcobalamin for Injection in the Treatment of Facial Neuritis)", 医学信息 (JOURNAL OF MEDICAL INFORMATION), vol. 27, no. 8, 31 August 2014 (2014-08-31)
CHANGQUAN WANG, LIU JUNLIAN; GONG ZUOJIONG: "Effect of acupoint injection combined with nerve growth factor injection on facial nerve function in patients with idiopathic facial palsy", CHINESE JOURNAL OF PRACTICAL NERVOUS DISEASES, vol. 20, no. 21, 15 November 2017 (2017-11-15), pages 24 - 26, XP093147492
Attorney, Agent or Firm:
BEIJING ZHIDA TONGCHENG INTELLECTUAL PROPERTY AGENCY (CN)
Download PDF: